Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China
· Delayed Price · Currency is CNY 62.48
+5.27 (9.21%)
Mar 10, 2026, 10:15 AM CST
105.46% (1Y)
| Market Cap | 9.97B |
| Revenue (ttm) | 1.33B |
| Net Income (ttm) | 283.25M |
| Shares Out | 174.35M |
| EPS (ttm) | 1.63 |
| PE Ratio | 35.10 |
| Forward PE | 32.88 |
| Dividend | 0.43 (0.74%) |
| Ex-Dividend Date | Jun 11, 2025 |
| Volume | 1,572,821 |
| Average Volume | 2,574,532 |
| Open | 57.92 |
| Previous Close | 57.21 |
| Day's Range | 57.32 - 62.48 |
| 52-Week Range | 29.89 - 73.66 |
| Beta | 0.22 |
| RSI | 42.14 |
| Earnings Date | Apr 22, 2026 |